Glial chemosensitivity: molecular mechanisms of pH sensing and interactions with

胶质细胞化学敏感性：pH 传感及其相互作用的分子机制

• 批准号: 8113330
• 负责人: DANIEL K MULKEY
• 金额: $ 36.85万
• 依托单位: UNIVERSITY OF CONNECTICUT STORRS
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-08-01 至 2015-07-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8113330
• 关键词: Address; Adenosine; Animals; Biological Neural Networks; Blood; Blood Circulation; Blood Vessels; Blood flow; Brain; Brain Stem; Breathing; Buffers; Caliber; Carbon Dioxide; Cell Nucleus; Cells; Central Sleep Apnea; Chemoreceptors; Electrophysiology (science); Frequencies; Genetic; Hypercapnic respiratory failure; Immunohistochemistry; In Vitro; Individual; Investigation; Knockout Mice; Lead; Measures; Mediating; Membrane Potentials; Messenger RNA; Microcirculation; Microscopy; Modeling; Molecular; Molecular Genetics; Neuroglia; Neurons; Output; Plethysmography; Population; Preparation; Proteins; Protocols documentation; Protoplasmic Astrocyte; Qualifying; Research; Respiratory Center; Signal Transduction; Site; Sleep; Slice; Source; Syndrome; Testing; Therapeutic; Tissues; Vasodilation; Video Microscopy; Voltage-Clamp Technics; Whole-Cell Recordings; base; cell type; defined contribution; disorder control; electrical property; in vivo; knockout animal; novel; novel therapeutics; public health relevance; receptor; respiratory; response; sensor; tool; voltage clamp

DESCRIPTION (provided by applicant): Central chemoreception is the mechanism by which specialized CO2/pH sensors (i.e., chemoreceptors) located in the brainstem regulates breathing in response to changes in tissue pH. This mechanism is important for normal breathing, especially during sleep, and disruption of chemoreception is thought to contribute to several pathological states including central sleep apnea, periodic breathing and central hypoventilation syndrome. Despite intensive investigation, cellular and molecular mechanisms underlying central chemoreception remain poorly understood. Recent evidence indicates that pH-sensitive neurons located in the retrotrapezoid nucleus (RTN) are important chemoreceptors. Evidence also indicates that CO2/H+-evoked ATP release in the RTN contributes to integrated output of the RTN and respiratory drive. We hypothesize that pH-sensitive RTN glial cells are the source of this purinergic drive to breathe. We propose that a discreet population of RTN glia sense H+ by inhibition of heteromeric Kir4.1-Kir5.1 channels, and release ATP to activate pH-sensitive neurons by activation of P2 receptors. We also propose that a portion of H+-evoked ATP released in the RTN will be hydrolyzed to adenosine and serve to limit chemoreceptor activity by initiating vasodilation to buffer tissue pH. The proposed research will use a combination of electrophysiological, immunohistochemical and genetic approaches to determine the cellular identity of pH-sensitive RTN glia, the molecular mechanism by which they sense pH, and their interactions with pH-sensitive neurons and local vasculature. The four specific aims of this project are: 1) determine the cellular identity of pH-sensitive RTN glia, 2) determine the molecular mechanism by which RTN glia sense changes in pH, 3) identify interactions between pH-sensitive glia and pH-sensitive neurons, 4) determine if pH-sensitive glia in the RTN modulate local microcirculation. It is our hope that determining these mechanisms will lead to new therapeutic avenues for the management of conditions resulting from suppressed respiratory drive. PUBLIC HEALTH RELEVANCE: The results of these studies will identity two novel mechanisms by which glial cells contribute to the mechanism by of chemoreception. Specifically, we will establish that a population of glial cells sense H+ by inhibition of Kir4.1-Kir5.1 channels and can provide an excitatory purinergic drive to the neural network that controls depth and frequency of breathing. We also determine that these pH-sensitive glia regulate vascular tone to help buffer tissue pH and limit chemoreceptor activity. Determining these basic cellular mechanisms will help guide new pharmacological approaches for the treatment of respiratory control disorders.

描述（由申请人提供）：中枢化学感受是专门的CO2/pH传感器（即，位于脑干的化学感受器）根据组织pH值的变化调节呼吸。这种机制对于正常呼吸非常重要，尤其是在睡眠期间，化学感受器的破坏被认为会导致多种病理状态，包括中枢性睡眠呼吸暂停、周期性呼吸和中枢性呼吸暂停。通气不足综合症。尽管深入研究，中枢化学感受的细胞和分子机制仍然知之甚少。最近的证据表明，位于后斜方核（RTN）的pH敏感神经元是重要的化学感受器。证据还表明，CO2/H+诱发的ATP释放的RTN和呼吸驱动的综合输出作出贡献。我们假设pH敏感的RTN神经胶质细胞是这种嘌呤能驱动呼吸的来源。我们认为RTN胶质细胞通过抑制异聚Kir4.1-Kir5.1通道感知H+，并通过激活P2受体释放ATP激活pH敏感神经元。我们还提出，在RTN中释放的一部分H+诱发的ATP将水解为腺苷，并通过启动血管舒张来缓冲组织pH来限制化学感受器活性。拟议的研究将使用电生理学，免疫组织化学和遗传学方法的组合来确定pH敏感性RTN胶质细胞的细胞身份，它们感知pH的分子机制，以及它们与pH敏感神经元和局部血管系统的相互作用。本研究的主要目的是：1）确定RTN中pH敏感胶质细胞的细胞特性; 2）确定RTN中pH敏感胶质细胞感知pH变化的分子机制; 3）确定RTN中pH敏感胶质细胞与pH敏感神经元之间的相互作用; 4）确定RTN中pH敏感胶质细胞是否调节局部微循环。我们希望，确定这些机制将导致新的治疗途径，用于管理由呼吸驱动抑制引起的疾病。 公共卫生相关性：这些研究的结果将确定两个新的机制，胶质细胞有助于化学感受的机制。具体来说，我们将建立一个群体的神经胶质细胞的感觉H+通过抑制Kir4.1-Kir5.1通道，并可以提供一个兴奋性嘌呤能驱动的神经网络，控制呼吸的深度和频率。我们还确定，这些pH敏感的神经胶质细胞调节血管张力，以帮助缓冲组织pH值和限制化学感受器的活动。确定这些基本的细胞机制将有助于指导治疗呼吸控制障碍的新的药理学方法。